CONMED Corporation (CNMD) Earnings Call Analysis

NYSE · Healthcare · Medical Devices

17/25

Growth 4 Margin 2 Expansion 5 Platform 2 Financial 4

latest quarter score

Earnings Reports

17
ConMed (CNMD) Q2 2026: EPS Guidance Rises $0.18 on Tariff Refund and Operational Upside
July 30, 2026
19
ConMed (CNMD) Q1 2026: Organic Growth Raised to 6.5% as GI Exit Sharpens Focus
April 30, 2026
22
ConMed (CNMD) Q4 2025: Ortho Sales Surge 12% as Supply Chain Progress Unlocks Growth
January 29, 2026
18
ConMed (CNMD) Q3 2025: $150M Buyback Replaces Dividend as Portfolio Focus Sharpens
November 06, 2025
18
ConMed (CNMD) Q2 2025: BioBrace and Buffalo Filter Fuel Double-Digit Growth, Orthopedic Share Losses Persist
July 30, 2025
17
ConMed (CNMD) Q1 2025: Supply Chain Savings Targeted at $20M, Margin Visibility Improves
July 04, 2025

Browse all companies